Mar 29 FDA approves second booster for people 50 and older By Lauran Neergaard, Matthew Perrone, Associated Press U.S. regulators are allowing people 50 and older to get another booster dose of the Pfizer or Moderna COVID-19 vaccine. Continue reading
Mar 18 Moderna seeks FDA authorization for 4th dose of COVID shot By Zeke Miller, Associated Press U.S. officials have been laying the groundwork to deliver additional booster doses to shore up the vaccines' protection against serious disease and death from COVID-19. The White House has been sounding the alarm that it needs Congress to “urgently” approve… Continue reading
Feb 15 Senate confirms Biden’s FDA pick after narrow vote By Matthew Perrone, Kevin Freking, Associated Press The Senate has narrowly confirmed President Joe Biden's pick to lead the Food and Drug Administration, filling a position that had been open for more than a year. Continue reading
Jan 23 Watch 4:34 How the U.S. could address confusing, shifting COVID-19 health directives By PBS NewsHour Two years since the first lockdown in China, there have been great strides to combat COVID-19, but confusion and questions remain. From vaccinations to testing, to masking and how many days to isolate—there hasn’t always been clarity. More collaboration between… Continue watching
Jan 03 As omicron surges, FDA expands Pfizer boosters for more teens By Lauran Neergaard, Associated Press The U.S. is expanding COVID-19 boosters as it confronts the omicron surge. The Food and Drug Administration on Monday allowed extra Pfizer shots for children as young as 12. Continue reading
Dec 14 WATCH: Senate hearing on the nomination of Robert Califf as commissioner of FDA By Ricardo Alonso-Zaldivar, Matthew Perrone, Associated Press President Joe Biden’s pick to lead the Food and Drug Administration deftly parried questions on crises ranging from the COVID pandemic to the opioid epidemic. Continue reading
Dec 09 U.S. expands Pfizer COVID boosters, allowing third dose to people as young as 16 By Lauran Neergaard, Mike Stobbe, Associated Press The Food and Drug Administration on Thursday cleared an extra dose for those ages 16 and 17, and the Centers for Disease Control and Prevention rapidly endorsed a booster for those ages. Continue reading
Dec 09 FDA expands Pfizer COVID booster, opens extra dose to age 16 By Lauren Neergaard and Matthew Perrone, Associated Press The U.S. and many other nations already urge adults to get a booster to pump up their immunity months after initial vaccination. Continue reading
Nov 30 FDA panel review final hurdle for Merck’s COVID-19 pill By Matthew Perrone, Associated Press U.S. health advisers are reviewing Merck's closely watched COVID-19 pill, which could become the first easy-to-use drug for American patients. Continue reading
Nov 16 Pfizer asks U.S. regulators to approve promising COVID pill By Matthew Perrone, Associated Press Pfizer is submitting its experimental pill for COVID-19 for U.S. authorization, setting the stage for a likely launch of the promising therapy in coming weeks. Continue reading